status quo of quo vadis? - KCE

More documents

Recommendations

Info

104 Quality development in general practice in Belgium: status quo or quo vadis ? KCE Reports 76 APPENDIX 7: INDICATORS USED IN THE QUALITY AND OUTCOMES FRAMEWORK - UK CLINICAL DOMAIN Secondary prevention of coronary heart disease Indicator Points Payment stages The practice can produce a register of patients with coronary heart disease. 4 The percentage of patients with newly diagnosed angina (diagnosed after 1 April 2003) who are referred for exercise testing and/or specialist assessment. 7 40-90% The percentage of patients with coronary heart disease whose notes have a record of blood pressure in the previous 15 months. 7 10-90% The percentage of patients with coronary heart disease in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less. 19 40-70% The percentage of patients with coronary heart disease whose notes have a record of total cholesterol in the previous 15 months. 7 40-90% The percentage of patients with coronary heart disease whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less. 17 40-70% The percentage of patients with coronary heart disease with a record in the previous 15 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded). 7 40-90% The percentage of patients with coronary heart disease who are currently treated with a beta blocker (unless a contraindication or side-effects are recorded). 7 40-60% The percentage of patients with a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor or Angiotensin II antagonist. 7 40-80% The percentage of patients with coronary heart disease who have a record of influenza immunisation in the preceding 1 September to 31 March. 7 40-90% Heart failure Indicator Points Payment stages The practice can produce a register of patients with heart failure. 4 The percentage of patients with a diagnosis of heart failure (diagnosed after 1 April 2006) which has been confirmed by an echocardiogram or by specialist assessment. 6 40-90% The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who can tolerate therapy and for whom there is no contraindication. 10 40-80%
KCE Reports 76 Quality development in general practice in Belgium: status quo or quo vadis ? 105 Stroke and TIA Indicator Points Payment stages The practice can produce a register of patients with Stroke or TIA. 2 The percentage of new patients with a stroke who have been referred for further investigation. 2 40-80% The percentage of patients with TIA or stroke who have a record of blood pressure in the notes in the preceding 15 months. 2 40-90% The percentage of patients with a history of TIA or stroke in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less. 5 40-70% The percentage of patients with TIA or stroke who have a record of total cholesterol in the last 15 months. 2 40-90% The percentage of patients with TIA or stroke whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less. 5 40-60% The percentage of patients with a stroke shown to be nonhaemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded). 4 40-90% The percentage of patients with TIA or stroke who have had influenza immunisation in the preceding 1 September to 31 March. 2 40-85% Hypertension Indicator Points Payment stages The practice can produce a register of patients with established hypertension. 6 The percentage of patients with hypertension in whom there is a record of the blood pressure in the previous nine months. 20 40-90% The percentage of patients with hypertension in whom the last blood pressure (measured in the previous nine months) is 150/90 or less. 57 40-70%
Page 1 and 2:
Kwaliteitsbevordering in de huisart
Page 3 and 4:
Kwaliteitsbevordering in de huisart
Page 5:
Hoe refereren naar dit document? Re
Page 8 and 9:
ii Kwaliteitsbevordering in de huis
Page 10 and 11:
iv Kwaliteitsbevordering in de huis
Page 12 and 13:
vi Kwaliteitsbevordering in de huis
Page 15 and 16:
KCE Reports 76 Quality development
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
21 Quality development in general p
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
KCE Reports Quality development in
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68: KCE Reports 76 Quality development
Page 117: KCE Reports 76 Quality development
Page 149 and 150: Health policy KCE Reports 76 Qualit
Page 151: KCE Reports 76 Quality development
Page 154 and 155: Wettelijk depot : D/2008/10.273/18
Page 156 and 157: 38. Baarmoederhalskankerscreening e
show all

status quo of quo vadis? - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?